Better breast biopsy marker retrieval in surgery
Part of Cancer, Skin clinical trials.
This trial compares two types of breast biopsy markers to see which one is easier for surgeons to find and remove during surgery. It may help make your surgery more precise and reduce the chance of leaving marker behind.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a breast biopsy marker (clip) placed and you are scheduled for surgery using a SCOUT localization device
- You are between 18 and 90 years old
- You are not an inmate
- You speak English
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special “marker” technique to help surgeons find affected lymph nodes in the armpit after chemotherapy. It may support more targeted surgery and help avoid unnecessary removal of healthy lymph nodes.
This trial tests a new surgical marker called Canopus that helps doctors find and remove breast tumors or affected lymph nodes during surgery. It may help you get more precise treatment.
This study looks at how a special ultrasound technique can help doctors better see tiny metal clips placed in the breast to mark areas needing surgery. If you had a clip placed to mark a suspicious breast lesion, this research could help improve how doctors locate it before surgery.
This trial compares two techniques for pinpointing non-touchable breast cancer during breast-conserving surgery. The study aims to see which method is more accurate and whether it leads to better surgical outcomes.
This trial tests a device called OneMark that helps doctors find and track breast cancer during surgery and follow-up. It may help make sure the cancer is removed completely.
This trial compares two techniques for finding breast tumors that cannot be felt by hand after initial (neoadjuvant) treatment. If successful, it may make breast-conserving surgery more accurate when the tumor has become “non-palpable.”
Hear when a new Breast Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.